Search

Genevieve S. Alley

Examiner (ID: 15273, Phone: (571)270-1111 , Office: P/1617 )

Most Active Art Unit
1617
Art Unit(s)
1617
Total Applications
873
Issued Applications
473
Pending Applications
109
Abandoned Applications
313

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17422391 [patent_doc_number] => 11255838 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-22 [patent_title] => Levels, functions, and resistances related to chronic conditions by using lysine-based supplements [patent_app_type] => utility [patent_app_number] => 16/865064 [patent_app_country] => US [patent_app_date] => 2020-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11436 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16865064 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/865064
Levels, functions, and resistances related to chronic conditions by using lysine-based supplements Apr 30, 2020 Issued
Array ( [id] => 16420607 [patent_doc_number] => 20200345805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-05 [patent_title] => COMPOSITIONS AND METHODS USEABLE FOR TREATMENT OF DRY EYE [patent_app_type] => utility [patent_app_number] => 16/854818 [patent_app_country] => US [patent_app_date] => 2020-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4842 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16854818 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/854818
COMPOSITIONS AND METHODS USEABLE FOR TREATMENT OF DRY EYE Apr 20, 2020 Abandoned
Array ( [id] => 16504672 [patent_doc_number] => 20200383928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-10 [patent_title] => BIODEGRADABLE EXTENDED RELEASE MICROSPHERE-HYDROGEL OCULAR DRUG DELIVERY SYSTEM AND METHOD [patent_app_type] => utility [patent_app_number] => 16/845184 [patent_app_country] => US [patent_app_date] => 2020-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13378 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16845184 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/845184
Biodegradable extended release microsphere-hydrogel ocular drug delivery system and method Apr 9, 2020 Issued
Array ( [id] => 16174736 [patent_doc_number] => 20200221704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => METHOD FOR PRODUCING A PLANT LIFE ENHANCING PRODUCT [patent_app_type] => utility [patent_app_number] => 16/833695 [patent_app_country] => US [patent_app_date] => 2020-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13626 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16833695 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/833695
METHOD FOR PRODUCING A PLANT LIFE ENHANCING PRODUCT Mar 29, 2020 Abandoned
Array ( [id] => 18353967 [patent_doc_number] => 11642351 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-09 [patent_title] => Eslicarbazepine suspension [patent_app_type] => utility [patent_app_number] => 16/827534 [patent_app_country] => US [patent_app_date] => 2020-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6978 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16827534 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/827534
Eslicarbazepine suspension Mar 22, 2020 Issued
Array ( [id] => 18792695 [patent_doc_number] => 11826429 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-28 [patent_title] => Pharmaceutical composition comprising brinzolamide [patent_app_type] => utility [patent_app_number] => 16/811674 [patent_app_country] => US [patent_app_date] => 2020-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 9655 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16811674 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/811674
Pharmaceutical composition comprising brinzolamide Mar 5, 2020 Issued
Array ( [id] => 16086847 [patent_doc_number] => 20200197410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-25 [patent_title] => D2O STABILIZED PHARMACEUTICAL FORMULATIONS [patent_app_type] => utility [patent_app_number] => 16/805612 [patent_app_country] => US [patent_app_date] => 2020-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39002 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16805612 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/805612
D2O stabilized pharmaceutical formulations Feb 27, 2020 Issued
Array ( [id] => 16266486 [patent_doc_number] => 20200267973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-27 [patent_title] => ALKALINE DISINFECTING COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/796990 [patent_app_country] => US [patent_app_date] => 2020-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7898 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16796990 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/796990
ALKALINE DISINFECTING COMPOSITIONS Feb 20, 2020 Pending
Array ( [id] => 20385425 [patent_doc_number] => 12485134 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-02 [patent_title] => Use of nicotinamide riboside, nicotinic acid riboside, reduced nicotinyl riboside compounds, and nicotinyl riboside compound derivatives in formulations [patent_app_type] => utility [patent_app_number] => 16/798207 [patent_app_country] => US [patent_app_date] => 2020-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 30 [patent_no_of_words] => 27281 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 240 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16798207 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/798207
Use of nicotinamide riboside, nicotinic acid riboside, reduced nicotinyl riboside compounds, and nicotinyl riboside compound derivatives in formulations Feb 20, 2020 Issued
Array ( [id] => 16435578 [patent_doc_number] => 20200352903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => Choline Esters [patent_app_type] => utility [patent_app_number] => 16/791265 [patent_app_country] => US [patent_app_date] => 2020-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6401 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16791265 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/791265
Choline Esters Feb 13, 2020 Abandoned
Array ( [id] => 18399303 [patent_doc_number] => 11661429 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-30 [patent_title] => Topical phosphoinositide 3-kinase inhibitors [patent_app_type] => utility [patent_app_number] => 16/783050 [patent_app_country] => US [patent_app_date] => 2020-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 29326 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 248 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16783050 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/783050
Topical phosphoinositide 3-kinase inhibitors Feb 4, 2020 Issued
Array ( [id] => 15926141 [patent_doc_number] => 20200154704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => FOOD CONTACT SURFACE SANITIZING LIQUID [patent_app_type] => utility [patent_app_number] => 16/773687 [patent_app_country] => US [patent_app_date] => 2020-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12963 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16773687 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/773687
Food contact surface sanitizing liquid Jan 26, 2020 Issued
Array ( [id] => 18012053 [patent_doc_number] => 11504327 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-11-22 [patent_title] => Method of preparing nanoparticles by hot-melt extrusion [patent_app_type] => utility [patent_app_number] => 16/748399 [patent_app_country] => US [patent_app_date] => 2020-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 33368 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16748399 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/748399
Method of preparing nanoparticles by hot-melt extrusion Jan 20, 2020 Issued
Array ( [id] => 15894869 [patent_doc_number] => 20200146953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => LIQUID CONCENTRATE FOR PRESERVING COSMETICS [patent_app_type] => utility [patent_app_number] => 16/741383 [patent_app_country] => US [patent_app_date] => 2020-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3480 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16741383 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/741383
LIQUID CONCENTRATE FOR PRESERVING COSMETICS Jan 12, 2020 Abandoned
Array ( [id] => 15895405 [patent_doc_number] => 20200147221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => HIGH CAPACITY DIKETOPIPERAZINE MICROPARTICLES AND METHODS [patent_app_type] => utility [patent_app_number] => 16/739506 [patent_app_country] => US [patent_app_date] => 2020-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10614 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16739506 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/739506
High capacity diketopiperazine microparticles and methods Jan 9, 2020 Issued
Array ( [id] => 17952420 [patent_doc_number] => 11478493 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-25 [patent_title] => Fabrication and application of a hetero-targeted nano-cocktail with traceless linkers [patent_app_type] => utility [patent_app_number] => 16/735977 [patent_app_country] => US [patent_app_date] => 2020-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 29 [patent_no_of_words] => 9237 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16735977 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/735977
Fabrication and application of a hetero-targeted nano-cocktail with traceless linkers Jan 6, 2020 Issued
Array ( [id] => 16236644 [patent_doc_number] => 20200253878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-13 [patent_title] => COMBINATIONS OF BETA-LACTAM COMPOUNDS AND PROBENECID AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/724527 [patent_app_country] => US [patent_app_date] => 2019-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32010 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16724527 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/724527
COMBINATIONS OF BETA-LACTAM COMPOUNDS AND PROBENECID AND USES THEREOF Dec 22, 2019 Abandoned
Array ( [id] => 17741375 [patent_doc_number] => 11389418 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-19 [patent_title] => Protection of polyunsaturated fatty acids from ruminal degradation [patent_app_type] => utility [patent_app_number] => 16/722358 [patent_app_country] => US [patent_app_date] => 2019-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6575 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16722358 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/722358
Protection of polyunsaturated fatty acids from ruminal degradation Dec 19, 2019 Issued
Array ( [id] => 17525707 [patent_doc_number] => 11298373 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-04-12 [patent_title] => Bowel cleansing chemical composition and associated use therefore [patent_app_type] => utility [patent_app_number] => 16/721688 [patent_app_country] => US [patent_app_date] => 2019-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4990 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16721688 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/721688
Bowel cleansing chemical composition and associated use therefore Dec 18, 2019 Issued
Array ( [id] => 15963641 [patent_doc_number] => 20200165572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-28 [patent_title] => ENGINEERED SUBSTRATES FOR HIGH-THROUGHPUT GENERATION OF 3D MODELS OF TUMOR DORMANCY, RELAPSE AND MICROMETASTASES FOR PHENOTYPE SPECIFIC DRUG DISCOVERY AND DEVELOPMENT [patent_app_type] => utility [patent_app_number] => 16/708027 [patent_app_country] => US [patent_app_date] => 2019-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19423 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16708027 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/708027
ENGINEERED SUBSTRATES FOR HIGH-THROUGHPUT GENERATION OF 3D MODELS OF TUMOR DORMANCY, RELAPSE AND MICROMETASTASES FOR PHENOTYPE SPECIFIC DRUG DISCOVERY AND DEVELOPMENT Dec 8, 2019 Abandoned
Menu